Previous 10 | Next 10 |
Quick Take Metacrine ( MTCR ) intends to raise $85 million from the sale of its common stock in an IPO, according to an amended registration statement . The company is developing treatment candidates for NASH conditions. MTCR is entering Phase 2 trials and will have significant capital ...
NEW YORK, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Mark Pruzanski, M.D., Presi...
Aimed at streamlining operations and reducing expenses while maintaining its focus on obeticholic acid (OCA) programs, the board of Intercept Pharmaceuticals ( ICPT -7.7% ) has adopted a plan to reduce its workforce by 25% or ~170 employees. More news on: Intercept Pharmaceuticals, Inc...
Data from Enanta Pharmaceuticals' (NASDAQ: ENTA ) development programs for non-alcoholic steatohepatitis (NASH) and hepatitis B virus (HBV) will be virtually presented at the European Association for the Study of the Liver Annual Meeting. More news on: Enanta Pharmaceuticals, Inc....
NEW YORK, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced additional data indicating that obetic...
Insider buying decreased last week with insiders purchasing $129.31 million of stock compared to $283.47 million in the week prior. Selling also decreased with insiders selling $2.09 billion of stock last week compared to $3.58 billion in the week prior. Sell/Buy Ratio: The insider Sell/Bu...
Volatility watch: Heading into the new week, short interest is on the rise on Royal Bank of Canada (NYSE: RY ) ahead of the bank's earnings report on August 26 and AstraZeneca (NYSE: AZN ) amid COVID-19 developments. Meanwhile, GameStop (NYSE: GME ) is cruising along with an exceedi...
Seanergy Maritime Holdings (NASDAQ: SHIP ) -52% after pricing public offering of ~35.7M units. More news on: Seanergy Maritime Holdings Corp., Poseida Therapeutics, Inc., Comstock Mining Inc., Stocks on the move, , Read more ...
Intercept Pharmaceuticals (NASDAQ: ICPT ) closed after-hours trading down 2.9% after reports of a 1.3M share block being offered up. More news on: Intercept Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
Introduction It’s closing in on almost 3-years since I first published my initial write-up on Viking Therapeutics ( VKTX ) back in Oct-2017. I’ve had plenty to say about the company since that time, publishing numerous other articles along the way, but more recently I’...
News, Short Squeeze, Breakout and More Instantly...
Intercept Pharmaceuticals Inc. Company Name:
ICPT Stock Symbol:
NASDAQ Market:
Intercept Pharmaceuticals Inc. Website:
MORRISTOWN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, today announced five abs...
sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBC Precedent-setting submission includes data from post-marketing studies COBALT and Study 401 as well as real-world evidence from a claims database and patient registries FDA has assign...
Data from two Phase 2 studies in PBC show combination of OCA + bezafibrate achieved biochemical remission (normalization of ALP, total bilirubin, GGT, ALT and AST) in 40-44% of patients in the first 12 weeks OCA 5 or 5-10 mg + bezafibrate 400 mg cohorts in both studies showed a >60% ...